These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24614684)

  • 21. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
    Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
    Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temperature-sensitive mutant of coxsackievirus B3 establishes resistance in neonatal mice that protects them during adolescence against coxsackievirus B3-induced myocarditis.
    Gauntt CJ; Paque RE; Trousdale MD; Gudvangen RJ; Barr DT; Lipotich GJ; Nealon TJ; Duffey PS
    Infect Immun; 1983 Feb; 39(2):851-64. PubMed ID: 6299950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis.
    Qi X; Xiong S
    Sci Rep; 2017 Feb; 7():41485. PubMed ID: 28148910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant coxsackievirus vectors for prevention and therapy of virus-induced heart disease.
    Henke A; Jarasch N; Martin U; Wegert J; Wildner A; Zell R; Wutzler P
    Int J Med Microbiol; 2008 Jan; 298(1-2):127-34. PubMed ID: 17897883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
    Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
    Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
    Wang Y; Gao B; Xiong S
    Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remission of CVB3-induced viral myocarditis by in vivo Th2 polarization via hydrodynamics-based interleukin-4 gene transfer.
    Jiang Z; Xu W; Li K; Yue Y; Xu L; Ye F; Xiong S
    J Gene Med; 2008 Aug; 10(8):918-29. PubMed ID: 18512734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
    Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
    Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.
    Fairweather D; Frisancho-Kiss S; Yusung SA; Barrett MA; Davis SE; Steele RA; Gatewood SJ; Rose NR
    J Immunol; 2005 Jan; 174(1):261-9. PubMed ID: 15611248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
    Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
    J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing activity induced by the attenuated coxsackievirus B3 Sabin3-like strain against CVB3 infection.
    Jrad-Battikh N; Souii A; Oueslati L; Aouni M; Hober D; Gharbi J; Ben M'hadheb-Gharbi M
    Curr Microbiol; 2014 Apr; 68(4):503-9. PubMed ID: 24322405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
    Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM
    Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
    Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis.
    Li Z; Yue Y; Xiong S
    Cardiovasc Pathol; 2013; 22(5):373-82. PubMed ID: 23523188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced protection against pulmonary mycobacterial challenge by chitosan-formulated polyepitope gene vaccine is associated with increased pulmonary secretory IgA and gamma-interferon(+) T cell responses.
    Ai W; Yue Y; Xiong S; Xu W
    Microbiol Immunol; 2013 Mar; 57(3):224-35. PubMed ID: 23489083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
    Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
    Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of immunoregulatory cytokines by recombinant coxsackievirus B3 variants confers protection against virus-caused myocarditis.
    Henke A; Zell R; Ehrlich G; Stelzner A
    J Virol; 2001 Sep; 75(17):8187-94. PubMed ID: 11483764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T lymphocyte responses in CVB3-induced murine myocarditis.
    Huber S; Polgar J; Moraska A; Cunningham M; Schwimmbeck P; Schultheiss P
    Scand J Infect Dis Suppl; 1993; 88():67-78. PubMed ID: 7685923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.